1hff: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:


==NMR solution structures of the vMIP-II 1-10 peptide from Kaposi's sarcoma-associated herpesvirus.==
==NMR solution structures of the vMIP-II 1-10 peptide from Kaposi's sarcoma-associated herpesvirus.==
<StructureSection load='1hff' size='340' side='right'caption='[[1hff]], [[NMR_Ensembles_of_Models | 55 NMR models]]' scene=''>
<StructureSection load='1hff' size='340' side='right'caption='[[1hff]]' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[1hff]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1HFF OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1HFF FirstGlance]. <br>
<table><tr><td colspan='2'>[[1hff]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Human_gammaherpesvirus_8 Human gammaherpesvirus 8]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1HFF OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1HFF FirstGlance]. <br>
</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[1hfg|1hfg]], [[1cm9|1cm9]], [[1vmp|1vmp]]</div></td></tr>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1hff FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1hff OCA], [https://pdbe.org/1hff PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1hff RCSB], [https://www.ebi.ac.uk/pdbsum/1hff PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1hff ProSAT]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1hff FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1hff OCA], [https://pdbe.org/1hff PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1hff RCSB], [https://www.ebi.ac.uk/pdbsum/1hff PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1hff ProSAT]</span></td></tr>
</table>
</table>
== Function ==
== Function ==
[[https://www.uniprot.org/uniprot/VMI2_HHV8P VMI2_HHV8P]] Blocks infection by several different human immunodeficiency virus type 1 (HIV-1) strains. This occurs because vMIP-II binds to a wide range of chemokine receptors. May form part of the response to host defenses contributing to virus-induced neoplasia and may have relevance to KSHV and HIV-I interactions.  
[https://www.uniprot.org/uniprot/VMI2_HHV8P VMI2_HHV8P] Blocks infection by several different human immunodeficiency virus type 1 (HIV-1) strains. This occurs because vMIP-II binds to a wide range of chemokine receptors. May form part of the response to host defenses contributing to virus-induced neoplasia and may have relevance to KSHV and HIV-I interactions.
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 22: Line 22:
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Human gammaherpesvirus 8]]
[[Category: Large Structures]]
[[Category: Large Structures]]
[[Category: Clark-Lewis, I]]
[[Category: Clark-Lewis I]]
[[Category: Crump, M P]]
[[Category: Crump MP]]
[[Category: Elisseeva, E]]
[[Category: Elisseeva E]]
[[Category: Gong, J H]]
[[Category: Gong JH]]
[[Category: Sykes, B D]]
[[Category: Sykes BD]]
[[Category: Anatagonist]]
[[Category: Chemokine]]
[[Category: Cxcr4]]
[[Category: Vmip-ii]]